ResMed Statistics
Total Valuation
ResMed has a market cap or net worth of AUD 61.40 billion. The enterprise value is 60.85 billion.
Market Cap | 61.40B |
Enterprise Value | 60.85B |
Important Dates
The next estimated earnings date is Thursday, October 23, 2025.
Earnings Date | Oct 23, 2025 |
Ex-Dividend Date | Aug 13, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.14% |
Shares Change (QoQ) | -0.12% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 145.48M |
Valuation Ratios
The trailing PE ratio is 28.74 and the forward PE ratio is 25.22.
PE Ratio | 28.74 |
Forward PE | 25.22 |
PS Ratio | 7.82 |
PB Ratio | 6.75 |
P/TBV Ratio | 16.39 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.81, with an EV/FCF ratio of 24.01.
EV / Earnings | 28.48 |
EV / Sales | 7.69 |
EV / EBITDA | 20.81 |
EV / EBIT | 23.41 |
EV / FCF | 24.01 |
Financial Position
The company has a current ratio of 3.44, with a Debt / Equity ratio of 0.14.
Current Ratio | 3.44 |
Quick Ratio | 2.16 |
Debt / Equity | 0.14 |
Debt / EBITDA | 0.45 |
Debt / FCF | 0.51 |
Interest Coverage | 2,884.43 |
Financial Efficiency
Return on equity (ROE) is 25.86% and return on invested capital (ROIC) is 16.80%.
Return on Equity (ROE) | 25.86% |
Return on Assets (ROA) | 14.02% |
Return on Invested Capital (ROIC) | 16.80% |
Return on Capital Employed (ROCE) | 23.58% |
Revenue Per Employee | 740,537 |
Profits Per Employee | 201,559 |
Employee Count | 10,600 |
Asset Turnover | 0.68 |
Inventory Turnover | 2.09 |
Taxes
In the past 12 months, ResMed has paid 422.27 million in taxes.
Income Tax | 422.27M |
Effective Tax Rate | 16.50% |
Stock Price Statistics
The stock price has increased by +16.90% in the last 52 weeks. The beta is 0.77, so ResMed's price volatility has been lower than the market average.
Beta (5Y) | 0.77 |
52-Week Price Change | +16.90% |
50-Day Moving Average | 41.75 |
200-Day Moving Average | 38.36 |
Relative Strength Index (RSI) | 46.24 |
Average Volume (20 Days) | 1,002,367 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 9.31 |
Income Statement
In the last 12 months, ResMed had revenue of AUD 7.85 billion and earned 2.14 billion in profits. Earnings per share was 14.51.
Revenue | 7.85B |
Gross Profit | 4.71B |
Operating Income | 2.57B |
Pretax Income | 2.56B |
Net Income | 2.14B |
EBITDA | 2.84B |
EBIT | 2.57B |
Earnings Per Share (EPS) | 14.51 |
Balance Sheet
The company has 1.84 billion in cash and 1.30 billion in debt, giving a net cash position of 545.50 million.
Cash & Cash Equivalents | 1.84B |
Total Debt | 1.30B |
Net Cash | 545.50M |
Net Cash Per Share | n/a |
Equity (Book Value) | 9.10B |
Book Value Per Share | 62.18 |
Working Capital | 3.79B |
Cash Flow
In the last 12 months, operating cash flow was 2.67 billion and capital expenditures -137.07 million, giving a free cash flow of 2.53 billion.
Operating Cash Flow | 2.67B |
Capital Expenditures | -137.07M |
Free Cash Flow | 2.53B |
FCF Per Share | n/a |
Margins
Gross margin is 59.99%, with operating and profit margins of 32.79% and 27.22%.
Gross Margin | 59.99% |
Operating Margin | 32.79% |
Pretax Margin | 32.60% |
Profit Margin | 27.22% |
EBITDA Margin | 36.15% |
EBIT Margin | 32.79% |
FCF Margin | 32.29% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.19%.
Dividend Per Share | 0.50 |
Dividend Yield | 1.19% |
Dividend Growth (YoY) | 11.72% |
Years of Dividend Growth | n/a |
Payout Ratio | 22.19% |
Buyback Yield | 0.14% |
Shareholder Yield | 1.34% |
Earnings Yield | 3.48% |
FCF Yield | 4.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on August 12, 2010. It was a forward split with a ratio of 2.
Last Split Date | Aug 12, 2010 |
Split Type | Forward |
Split Ratio | 2 |
Scores
ResMed has an Altman Z-Score of 12.06 and a Piotroski F-Score of 7.
Altman Z-Score | 12.06 |
Piotroski F-Score | 7 |